BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LCAR-F33S readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of LCAR-F33S\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07100067-3248@assetmemo.bio
DTSTAMP:20261121T005022Z
DTSTART;VALUE=DATE:20280220
DTEND;VALUE=DATE:20280221
SUMMARY:LCAR-F33S: Phase na readout est. (NCT07100067)
DESCRIPTION:LCAR-F33S\, phase na\, Multiple Myeloma.\nStudy: LCAR-F33S in T
 reatment of Relapsed/Refractory Multiple Myeloma\nEstimated primary comple
 tion: 20 February 2028. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/lcar-f33s#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT07100067
URL:https://assetmemo.bio/drug/lcar-f33s#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
